Adult‐onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity
Cystic fibrosis (CF) liver disease (CFLD), a leading cause of death in CF, is mostly described in pediatric populations. Adult‐onset CFLD lacks sufficient characterization and diagnostic tools. A cohort of CF patients without CFLD during childhood were followed for up to 38 years with serologic test...
Saved in:
| Published in | Hepatology (Baltimore, Md.) Vol. 66; no. 2; pp. 591 - 601 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Wolters Kluwer Health, Inc
01.08.2017
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Cystic fibrosis (CF) liver disease (CFLD), a leading cause of death in CF, is mostly described in pediatric populations. Adult‐onset CFLD lacks sufficient characterization and diagnostic tools. A cohort of CF patients without CFLD during childhood were followed for up to 38 years with serologic testing, imaging, and noninvasive fibrosis markers. Historical CFLD diagnostic criteria were compared with newly proposed CFLD criteria. Thirty‐six CF patients were followed for a median of 24.5 years (interquartile range 15.6‐32.9). By the last follow‐up, 11 (31%) had died. With conventional criteria, 8 (22%) patients had CFLD; and by the new criteria, 17 (47%) had CFLD at a median age of 36.6 years (interquartile range 26.5‐43.2). By the new criteria, those with CFLD had higher median alanine aminotransferase (42 versus 27, P = 0.005), aspartate aminotransferase (AST; 26 versus 21, P = 0.01), direct bilirubin (0.13 versus 0.1, P = 0.01), prothrombin time (14.4 versus 12.4, P = 0.002), and AST‐to‐platelet ratio index (0.31 versus 0.23, P = 0.003) over the last 2 years of follow‐up. Subjects with a FibroScan >6.8 kPa had higher alanine aminotransferase (42 versus 28U/L, P = 0.02), AST (35 versus 25U/L, P = 0.02), AST‐to‐platelet ratio index (0.77 versus 0.25, P = 0.0004), and Fibrosis‐4 index (2.14 versus 0.74, P = 0.0003) and lower platelet counts (205 versus 293, P = 0.02). One CFLD patient had nodular regenerative hyperplasia. Longitudinally, mean platelet counts significantly declined in the CFLD group (from 310 to 230 U/L, P = 0.0005). Deceased CFLD patients had lower platelet counts than those alive with CFLD (143 versus 258 U/L, P = 0.004) or those deceased with no CFLD (143 versus 327U/L, P = 0.006). Conclusion: Adult‐onset CFLD may be more prevalent than previously described, which suggests a later wave of CFLD that impacts morbidity; routine liver tests, radiologic imaging, noninvasive fibrosis markers, and FibroScan can be used algorithmically to identify adult CFLD; and further evaluation in other CF cohorts should be performed for validation. (Hepatology 2017;66:591–601). |
|---|---|
| AbstractList | Cystic fibrosis (CF) liver disease (CFLD), a leading cause of death in CF, is mostly described in pediatric populations. Adult-onset CFLD lacks sufficient characterization and diagnostic tools. A cohort of CF patients without CFLD during childhood were followed for up to 38 years with serologic testing, imaging, and noninvasive fibrosis markers. Historical CFLD diagnostic criteria were compared with newly proposed CFLD criteria. Thirty-six CF patients were followed for a median of 24.5 years (interquartile range 15.6-32.9). By the last follow-up, 11 (31%) had died. With conventional criteria, 8 (22%) patients had CFLD; and by the new criteria, 17 (47%) had CFLD at a median age of 36.6 years (interquartile range 26.5-43.2). By the new criteria, those with CFLD had higher median alanine aminotransferase (42 versus 27, P = 0.005), aspartate aminotransferase (AST; 26 versus 21, P = 0.01), direct bilirubin (0.13 versus 0.1, P = 0.01), prothrombin time (14.4 versus 12.4, P = 0.002), and AST-to-platelet ratio index (0.31 versus 0.23, P = 0.003) over the last 2 years of follow-up. Subjects with a FibroScan >6.8 kPa had higher alanine aminotransferase (42 versus 28U/L, P = 0.02), AST (35 versus 25U/L, P = 0.02), AST-to-platelet ratio index (0.77 versus 0.25, P = 0.0004), and Fibrosis-4 index (2.14 versus 0.74, P = 0.0003) and lower platelet counts (205 versus 293, P = 0.02). One CFLD patient had nodular regenerative hyperplasia. Longitudinally, mean platelet counts significantly declined in the CFLD group (from 310 to 230 U/L, P = 0.0005). Deceased CFLD patients had lower platelet counts than those alive with CFLD (143 versus 258 U/L, P = 0.004) or those deceased with no CFLD (143 versus 327U/L, P = 0.006).
Adult-onset CFLD may be more prevalent than previously described, which suggests a later wave of CFLD that impacts morbidity; routine liver tests, radiologic imaging, noninvasive fibrosis markers, and FibroScan can be used algorithmically to identify adult CFLD; and further evaluation in other CF cohorts should be performed for validation. (Hepatology 2017;66:591-601). Cystic fibrosis (CF) liver disease (CFLD), a leading cause of death in CF, is mostly described in pediatric populations. Adult‐onset CFLD lacks sufficient characterization and diagnostic tools. A cohort of CF patients without CFLD during childhood were followed for up to 38 years with serologic testing, imaging, and noninvasive fibrosis markers. Historical CFLD diagnostic criteria were compared with newly proposed CFLD criteria. Thirty‐six CF patients were followed for a median of 24.5 years (interquartile range 15.6‐32.9). By the last follow‐up, 11 (31%) had died. With conventional criteria, 8 (22%) patients had CFLD; and by the new criteria, 17 (47%) had CFLD at a median age of 36.6 years (interquartile range 26.5‐43.2). By the new criteria, those with CFLD had higher median alanine aminotransferase (42 versus 27, P = 0.005), aspartate aminotransferase (AST; 26 versus 21, P = 0.01), direct bilirubin (0.13 versus 0.1, P = 0.01), prothrombin time (14.4 versus 12.4, P = 0.002), and AST‐to‐platelet ratio index (0.31 versus 0.23, P = 0.003) over the last 2 years of follow‐up. Subjects with a FibroScan >6.8 kPa had higher alanine aminotransferase (42 versus 28U/L, P = 0.02), AST (35 versus 25U/L, P = 0.02), AST‐to‐platelet ratio index (0.77 versus 0.25, P = 0.0004), and Fibrosis‐4 index (2.14 versus 0.74, P = 0.0003) and lower platelet counts (205 versus 293, P = 0.02). One CFLD patient had nodular regenerative hyperplasia. Longitudinally, mean platelet counts significantly declined in the CFLD group (from 310 to 230 U/L, P = 0.0005). Deceased CFLD patients had lower platelet counts than those alive with CFLD (143 versus 258 U/L, P = 0.004) or those deceased with no CFLD (143 versus 327U/L, P = 0.006). Conclusion : Adult‐onset CFLD may be more prevalent than previously described, which suggests a later wave of CFLD that impacts morbidity; routine liver tests, radiologic imaging, noninvasive fibrosis markers, and FibroScan can be used algorithmically to identify adult CFLD; and further evaluation in other CF cohorts should be performed for validation. (H epatology 2017;66:591–601). Cystic fibrosis (CF) liver disease (CFLD), a leading cause of death in CF, is mostly described in pediatric populations. Adult-onset CFLD lacks sufficient characterization and diagnostic tools. A cohort of CF patients without CFLD during childhood were followed for up to 38 years with serologic testing, imaging, and noninvasive fibrosis markers. Historical CFLD diagnostic criteria were compared with newly proposed CFLD criteria. Thirty-six CF patients were followed for a median of 24.5 years (interquartile range 15.6-32.9). By the last follow-up, 11 (31%) had died. With conventional criteria, 8 (22%) patients had CFLD; and by the new criteria, 17 (47%) had CFLD at a median age of 36.6 years (interquartile range 26.5-43.2). By the new criteria, those with CFLD had higher median alanine aminotransferase (42 versus 27, P = 0.005), aspartate aminotransferase (AST; 26 versus 21, P = 0.01), direct bilirubin (0.13 versus 0.1, P = 0.01), prothrombin time (14.4 versus 12.4, P = 0.002), and AST-to-platelet ratio index (0.31 versus 0.23, P = 0.003) over the last 2 years of follow-up. Subjects with a FibroScan >6.8 kPa had higher alanine aminotransferase (42 versus 28U/L, P = 0.02), AST (35 versus 25U/L, P = 0.02), AST-to-platelet ratio index (0.77 versus 0.25, P = 0.0004), and Fibrosis-4 index (2.14 versus 0.74, P = 0.0003) and lower platelet counts (205 versus 293, P = 0.02). One CFLD patient had nodular regenerative hyperplasia. Longitudinally, mean platelet counts significantly declined in the CFLD group (from 310 to 230 U/L, P = 0.0005). Deceased CFLD patients had lower platelet counts than those alive with CFLD (143 versus 258 U/L, P = 0.004) or those deceased with no CFLD (143 versus 327U/L, P = 0.006).Cystic fibrosis (CF) liver disease (CFLD), a leading cause of death in CF, is mostly described in pediatric populations. Adult-onset CFLD lacks sufficient characterization and diagnostic tools. A cohort of CF patients without CFLD during childhood were followed for up to 38 years with serologic testing, imaging, and noninvasive fibrosis markers. Historical CFLD diagnostic criteria were compared with newly proposed CFLD criteria. Thirty-six CF patients were followed for a median of 24.5 years (interquartile range 15.6-32.9). By the last follow-up, 11 (31%) had died. With conventional criteria, 8 (22%) patients had CFLD; and by the new criteria, 17 (47%) had CFLD at a median age of 36.6 years (interquartile range 26.5-43.2). By the new criteria, those with CFLD had higher median alanine aminotransferase (42 versus 27, P = 0.005), aspartate aminotransferase (AST; 26 versus 21, P = 0.01), direct bilirubin (0.13 versus 0.1, P = 0.01), prothrombin time (14.4 versus 12.4, P = 0.002), and AST-to-platelet ratio index (0.31 versus 0.23, P = 0.003) over the last 2 years of follow-up. Subjects with a FibroScan >6.8 kPa had higher alanine aminotransferase (42 versus 28U/L, P = 0.02), AST (35 versus 25U/L, P = 0.02), AST-to-platelet ratio index (0.77 versus 0.25, P = 0.0004), and Fibrosis-4 index (2.14 versus 0.74, P = 0.0003) and lower platelet counts (205 versus 293, P = 0.02). One CFLD patient had nodular regenerative hyperplasia. Longitudinally, mean platelet counts significantly declined in the CFLD group (from 310 to 230 U/L, P = 0.0005). Deceased CFLD patients had lower platelet counts than those alive with CFLD (143 versus 258 U/L, P = 0.004) or those deceased with no CFLD (143 versus 327U/L, P = 0.006).Adult-onset CFLD may be more prevalent than previously described, which suggests a later wave of CFLD that impacts morbidity; routine liver tests, radiologic imaging, noninvasive fibrosis markers, and FibroScan can be used algorithmically to identify adult CFLD; and further evaluation in other CF cohorts should be performed for validation. (Hepatology 2017;66:591-601).CONCLUSIONAdult-onset CFLD may be more prevalent than previously described, which suggests a later wave of CFLD that impacts morbidity; routine liver tests, radiologic imaging, noninvasive fibrosis markers, and FibroScan can be used algorithmically to identify adult CFLD; and further evaluation in other CF cohorts should be performed for validation. (Hepatology 2017;66:591-601). Cystic fibrosis (CF) liver disease (CFLD), a leading cause of death in CF, is mostly described in pediatric populations. Adult‐onset CFLD lacks sufficient characterization and diagnostic tools. A cohort of CF patients without CFLD during childhood were followed for up to 38 years with serologic testing, imaging, and noninvasive fibrosis markers. Historical CFLD diagnostic criteria were compared with newly proposed CFLD criteria. Thirty‐six CF patients were followed for a median of 24.5 years (interquartile range 15.6‐32.9). By the last follow‐up, 11 (31%) had died. With conventional criteria, 8 (22%) patients had CFLD; and by the new criteria, 17 (47%) had CFLD at a median age of 36.6 years (interquartile range 26.5‐43.2). By the new criteria, those with CFLD had higher median alanine aminotransferase (42 versus 27, P = 0.005), aspartate aminotransferase (AST; 26 versus 21, P = 0.01), direct bilirubin (0.13 versus 0.1, P = 0.01), prothrombin time (14.4 versus 12.4, P = 0.002), and AST‐to‐platelet ratio index (0.31 versus 0.23, P = 0.003) over the last 2 years of follow‐up. Subjects with a FibroScan >6.8 kPa had higher alanine aminotransferase (42 versus 28U/L, P = 0.02), AST (35 versus 25U/L, P = 0.02), AST‐to‐platelet ratio index (0.77 versus 0.25, P = 0.0004), and Fibrosis‐4 index (2.14 versus 0.74, P = 0.0003) and lower platelet counts (205 versus 293, P = 0.02). One CFLD patient had nodular regenerative hyperplasia. Longitudinally, mean platelet counts significantly declined in the CFLD group (from 310 to 230 U/L, P = 0.0005). Deceased CFLD patients had lower platelet counts than those alive with CFLD (143 versus 258 U/L, P = 0.004) or those deceased with no CFLD (143 versus 327U/L, P = 0.006). Conclusion: Adult‐onset CFLD may be more prevalent than previously described, which suggests a later wave of CFLD that impacts morbidity; routine liver tests, radiologic imaging, noninvasive fibrosis markers, and FibroScan can be used algorithmically to identify adult CFLD; and further evaluation in other CF cohorts should be performed for validation. (Hepatology 2017;66:591–601). |
| Author | Sakiani, Sasan Herion, David Eccleston, Jason Kleiner, David E. Hoofnagle, Jay H. Heller, Theo Chernick, Milica Koh, Christopher Liang, T. Jake Surana, Pallavi Zhao, Xiongce |
| AuthorAffiliation | 4 Department of Clinical Research Informatics, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA 3 Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA 2 Office of the Director, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA 1 Liver Diseases Branch, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA |
| AuthorAffiliation_xml | – name: 3 Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA – name: 4 Department of Clinical Research Informatics, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA – name: 1 Liver Diseases Branch, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA – name: 2 Office of the Director, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA |
| Author_xml | – sequence: 1 givenname: Christopher surname: Koh fullname: Koh, Christopher email: Christopher.koh@nih.gov organization: National Institutes of Health – sequence: 2 givenname: Sasan surname: Sakiani fullname: Sakiani, Sasan organization: MetroHealth Medical Center – sequence: 3 givenname: Pallavi surname: Surana fullname: Surana, Pallavi organization: National Institutes of Health – sequence: 4 givenname: Xiongce surname: Zhao fullname: Zhao, Xiongce organization: MetroHealth Medical Center – sequence: 5 givenname: Jason surname: Eccleston fullname: Eccleston, Jason organization: National Institutes of Health – sequence: 6 givenname: David E. surname: Kleiner fullname: Kleiner, David E. organization: National Cancer Institute, National Institutes of Health – sequence: 7 givenname: David surname: Herion fullname: Herion, David organization: Clinical Center, National Institutes of Health – sequence: 8 givenname: T. Jake surname: Liang fullname: Liang, T. Jake organization: National Institutes of Health – sequence: 9 givenname: Jay H. surname: Hoofnagle fullname: Hoofnagle, Jay H. organization: National Institutes of Health – sequence: 10 givenname: Milica surname: Chernick fullname: Chernick, Milica organization: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health – sequence: 11 givenname: Theo surname: Heller fullname: Heller, Theo email: TheoH@intra.niddk.nih.gov organization: National Institutes of Health |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28422310$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1UU1v1DAUtFAR3S4c-AMoEhc4pPVHEsccKlWlUKRKcICz5Tgv3Vdl7WA7RcuJn8Bv5JdgdrcIKjhZem9mPG_miBw474CQp4weM0r5yQqmY644kw_IgtVclkLU9IAsKJe0VEyoQ3IU4w2lVFW8fUQOeVtxLhhdEDzr5zH9-PbduwipsJuY0BYDdsFHjMWItxCKHiOYCK-K12iu3XZhXF_YlQnGJgj41ST0rvBDnhez6yGYaQpg0SToC3AJ0-YxeTiYMcKT_bskn95cfDy_LK_ev313fnZV2qoSsmRWykoy0XRS5ltqA51oBtq0vWxEI6WiUrZCDMK2dd3YgVLZUWCisoorJYxYktOd7jR3a-ht_j2YUU8B1yZstDeo_944XOlrf6vrmuV4WBZ4sRcI_vMMMek1RgvjaBz4OWrWtko2dZsTXJLn96A3fg4un6eZ4pQ2Ssgqo5796ei3lbsWMuBkB7A59Rhg0BbTNtJsEEfNqP7Vs849623PmfHyHuNO9F_YvfoXHGHzf6C-vPiwY_wENaW4NA |
| CitedBy_id | crossref_primary_10_1016_j_path_2023_04_005 crossref_primary_10_1371_journal_pone_0318085 crossref_primary_10_3138_canlivj_2020_0008 crossref_primary_10_1016_j_rgmx_2022_05_003 crossref_primary_10_1097_MPG_0000000000003194 crossref_primary_10_3390_ijms21228586 crossref_primary_10_1002_jum_15482 crossref_primary_10_4254_wjh_v10_i1_34 crossref_primary_10_1002_hep4_1719 crossref_primary_10_17235_reed_2022_9289_2022 crossref_primary_10_1097_MPG_0000000000002412 crossref_primary_10_1093_pnasnexus_pgac306 crossref_primary_10_3390_diagnostics14050538 crossref_primary_10_1016_j_jaci_2021_05_028 crossref_primary_10_1097_MPG_0000000000002413 crossref_primary_10_14814_phy2_14978 crossref_primary_10_3138_canlivj_2018_0019 crossref_primary_10_1097_MPG_0000000000003944 crossref_primary_10_1002_lt_25421 crossref_primary_10_1111_ctr_13269 crossref_primary_10_1016_j_toxrep_2020_09_014 crossref_primary_10_1016_j_jcf_2018_11_009 crossref_primary_10_1080_17476348_2019_1552832 crossref_primary_10_1002_hep_30255 crossref_primary_10_23736_S0026_4946_20_05895_8 crossref_primary_10_3390_ijms242115766 crossref_primary_10_1016_j_clinre_2022_101977 crossref_primary_10_4274_dir_2022_221818 crossref_primary_10_1111_liv_15963 crossref_primary_10_1111_his_15409 crossref_primary_10_1111_apt_16749 crossref_primary_10_1016_j_jcmgh_2019_04_013 crossref_primary_10_1371_journal_pone_0212779 crossref_primary_10_1002_hep_29637 crossref_primary_10_1002_hep_30148 crossref_primary_10_1016_j_pneumo_2018_09_012 crossref_primary_10_1097_MPG_0000000000002441 crossref_primary_10_1111_dth_13272 crossref_primary_10_12688_hrbopenres_13065_3 crossref_primary_10_1002_ppul_26892 crossref_primary_10_12688_hrbopenres_13065_2 crossref_primary_10_12688_hrbopenres_13065_1 crossref_primary_10_1016_j_jcf_2025_02_007 crossref_primary_10_1016_j_jpedsurg_2019_01_035 crossref_primary_10_1097_MOG_0000000000000624 crossref_primary_10_1016_j_jcte_2021_100283 crossref_primary_10_4254_wjh_v11_i12_761 crossref_primary_10_1002_lt_25496 crossref_primary_10_22141_2308_2097_58_3_2024_625 crossref_primary_10_1007_s10620_024_08784_0 crossref_primary_10_1016_j_jpeds_2019_12_033 crossref_primary_10_1016_j_rgmxen_2022_07_002 crossref_primary_10_1016_j_heliyon_2023_e21861 crossref_primary_10_1016_j_path_2018_02_001 crossref_primary_10_3389_fmed_2021_598382 crossref_primary_10_1002_hep4_1266 crossref_primary_10_1016_j_jhep_2021_09_042 crossref_primary_10_1002_ppul_24081 crossref_primary_10_1007_s00330_018_5650_5 crossref_primary_10_1097_MPG_0000000000002872 crossref_primary_10_1097_HEP_0000000000000646 crossref_primary_10_1016_j_humpath_2023_01_003 crossref_primary_10_1097_MOG_0000000000000432 crossref_primary_10_1111_liv_15748 crossref_primary_10_1016_j_ccm_2022_07_001 crossref_primary_10_1097_MCP_0000000000000428 crossref_primary_10_1080_00365521_2018_1534986 crossref_primary_10_1007_s00247_024_05979_5 crossref_primary_10_1002_cld_845 crossref_primary_10_3138_canlivj_2020_0012 crossref_primary_10_1016_j_jcf_2018_08_009 crossref_primary_10_1155_2022_4798136 crossref_primary_10_1016_j_jcf_2023_09_006 crossref_primary_10_1016_j_jcf_2021_11_015 crossref_primary_10_1136_flgastro_2020_101610 crossref_primary_10_1016_j_cld_2018_12_008 |
| Cites_doi | 10.1016/j.jcf.2009.08.001 10.1002/hep.28016 10.1016/j.thromres.2015.02.010 10.1111/liv.12958 10.1002/hep.21178 10.1002/hep.24014 10.1097/MPG.0000000000001448 10.1016/j.cgh.2016.03.041 10.1016/j.jcf.2007.10.004 10.1016/j.jcf.2012.11.010 10.1056/NEJMra043184 10.1002/hep.1840360613 10.1111/liv.12113 10.1155/2015/138530 10.1371/journal.pone.0042139 10.1016/j.jcf.2013.04.004 10.1053/jhep.2003.50346 10.1016/j.jhep.2008.02.008 10.3111/13696998.2011.562266 10.1097/MCG.0b013e31819e8bbd 10.1002/hep.1840110512 10.1002/hep.21258 10.1002/hep.510300527 10.1016/S0022-3476(94)70361-2 10.1097/MCP.0b013e3282f10a16 10.1016/j.ultrasmedbio.2015.11.011 10.1016/j.cgh.2005.12.013 10.1002/hep.21524 10.1016/j.ultrasmedbio.2003.07.001 10.1111/j.1572-0241.1998.044_c.x 10.1053/j.gastro.2008.02.081 10.1016/S0022-3476(95)70113-3 10.1007/s00247-009-1531-z 10.1001/archinte.163.2.218 10.1080/00365520802158614 10.1002/hep.27950 10.1111/apt.12273 10.1007/s10875-013-9873-6 |
| ContentType | Journal Article |
| Copyright | Published 2017. This article is a U.S. Government work and is in the public domain in the USA. 2017 by the American Association for the Study of Liver Diseases. |
| Copyright_xml | – notice: Published 2017. This article is a U.S. Government work and is in the public domain in the USA. – notice: 2017 by the American Association for the Study of Liver Diseases. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 H94 K9. 7X8 5PM |
| DOI | 10.1002/hep.29217 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1527-3350 |
| EndPage | 601 |
| ExternalDocumentID | PMC5519421 28422310 10_1002_hep_29217 HEP29217 |
| Genre | article Journal Article Comparative Study Research Support, N.I.H., Intramural |
| GrantInformation_xml | – fundername: National Institute of Diabetes and Digestive and Kidney Diseases – fundername: National Cancer Institute – fundername: Intramural NIH HHS grantid: Z99 DK999999 |
| GroupedDBID | --- --K .3N .55 .GA .GJ .Y3 05W 0R~ 10A 186 1B1 1CY 1L6 1OB 1OC 1ZS 1~5 24P 31~ 33P 3O- 3SF 3WU 4.4 4G. 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AALRI AANHP AAONW AAQFI AAQQT AAQXK AASGY AAXRX AAXUO AAZKR ABCQN ABCUV ABEML ABIJN ABLJU ABMAC ABOCM ABPVW ABWVN ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACLDA ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADMUD ADNMO ADOZA ADXAS ADZMN ADZOD AECAP AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFFNX AFGKR AFPWT AFUWQ AFZJQ AHMBA AIACR AIURR AIWBW AJAOE AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD F00 F01 F04 F5P FD8 FDB FEDTE FGOYB FUBAC G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IHE IX1 J0M J5H JPC KBYEO KQQ LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 M65 MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ NNB NQ- O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K R2- RGB RIG RIWAO RJQFR ROL RPZ RWI RX1 RYL SEW SSZ SUPJJ TEORI UB1 V2E V9Y W2D W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXI X7M XG1 XV2 ZGI ZXP ZZTAW ~IA ~WT AAYXX ABJNI ACZKN AFNMH AGQPQ AHQVU CITATION MEWTI WXSBR AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 ADSXY H94 K9. 7X8 5PM |
| ID | FETCH-LOGICAL-c4437-1c7747136b771525aeb36f068d7636779077833f3c8556cf007b0e134c92993a3 |
| IEDL.DBID | DR2 |
| ISSN | 0270-9139 1527-3350 |
| IngestDate | Thu Aug 21 18:07:37 EDT 2025 Tue Aug 05 09:29:22 EDT 2025 Wed Aug 13 09:35:49 EDT 2025 Mon Jul 21 06:02:43 EDT 2025 Thu Apr 24 23:09:10 EDT 2025 Tue Jul 01 03:33:49 EDT 2025 Wed Jan 22 16:58:02 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| License | Published 2017. This article is a U.S. Government work and is in the public domain in the USA. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4437-1c7747136b771525aeb36f068d7636779077833f3c8556cf007b0e134c92993a3 |
| Notes | These authors share senior authorship. Supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases and the National Cancer Institute of the National Institutes of Health. Potential conflict of interest: Nothing to report. These authors share first authorship. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 Share first authorship Share senior authorship |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/5519421 |
| PMID | 28422310 |
| PQID | 1920069374 |
| PQPubID | 996352 |
| PageCount | 11 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5519421 proquest_miscellaneous_1889765822 proquest_journals_1920069374 pubmed_primary_28422310 crossref_citationtrail_10_1002_hep_29217 crossref_primary_10_1002_hep_29217 wiley_primary_10_1002_hep_29217_HEP29217 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | August 2017 |
| PublicationDateYYYYMMDD | 2017-08-01 |
| PublicationDate_xml | – month: 08 year: 2017 text: August 2017 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Hoboken |
| PublicationTitle | Hepatology (Baltimore, Md.) |
| PublicationTitleAlternate | Hepatology |
| PublicationYear | 2017 |
| Publisher | Wolters Kluwer Health, Inc |
| Publisher_xml | – name: Wolters Kluwer Health, Inc |
| References | 2015; 35 2002; 36 2017; 64 1990; 11 2009; 43 2005; 352 2011 1999; 28 2011; 53 2008; 7 2011; 10 2003; 38 2001; 48 2006; 4 2011; 14 2007; 13 2016; 14 2010; 40 1994; 124 2013; 37 2015; 29 2013; 33 2015; 62 2006; 43 2015; 135 2013; 12 2006; 44 2008; 48 2016; 42 2009; 8 1995; 127 2008; 43 1999; 30 2001; 2 2003; 29 1998; 93 2008; 134 2012; 7 2007; 45 2009; 16 2003; 163 (hep29217-bib-0031-20241017) 2017; 64 (hep29217-bib-0001-20241017) 2007; 13 (hep29217-bib-0019-20241017) 2006; 43 (hep29217-bib-0024-20241017) 2011; 14 (hep29217-bib-0006-20241017) 1999; 30 (hep29217-bib-0022-20241017) 2003; 163 (hep29217-bib-0002-20241017) 2005; 352 (hep29217-bib-0013-20241017) 2013; 12 (hep29217-bib-0015-20241017) 2013; 12 (hep29217-bib-0026-20241017) 2016; 14 (hep29217-bib-0004-20241017) 2009; 43 (hep29217-bib-0029-20241017) 2016; 42 (hep29217-bib-0035-20241017) 2013; 37 (hep29217-bib-0040-20241017) 2006; 44 (hep29217-bib-0018-20241017) 2003; 38 (hep29217-bib-0033-20241017) 2015; 62 (hep29217-bib-0041-20241017) 2001; 48 (hep29217-bib-0017-20241017) 2015; 62 (hep29217-bib-0037-20241017) 2007; 45 (hep29217-bib-0039-20241017) 1995; 127 (hep29217-bib-0030-20241017) 2009; 16 (hep29217-bib-0011-20241017) 2013; 33 (hep29217-bib-0036-20241017) 2013; 33 (hep29217-bib-0010-20241017) 2008; 7 (hep29217-bib-0032-20241017) 2015; 29 (hep29217-bib-0023-20241017) 2008; 48 (hep29217-bib-0028-20241017) 2010; 40 (hep29217-bib-0043-20241017) 2015; 35 (hep29217-bib-0012-20241017) 2011; 10 (hep29217-bib-0016-20241017) 2012; 7 (hep29217-bib-0025-20241017) 2008; 134 (hep29217-bib-0020-20241017) 2008; 43 (hep29217-bib-0007-20241017) 2001; 2 (hep29217-bib-0009-20241017) 2002; 36 (hep29217-bib-0005-20241017) 1999; 28 (hep29217-bib-0027-20241017) 2009; 8 (hep29217-bib-0044-20241017) 2003; 29 (hep29217-bib-0008-20241017) 1994; 124 (hep29217-bib-0034-20241017) 2015; 135 (hep29217-bib-0042-20241017) 1990; 11 (hep29217-bib-0014-20241017) 2011; 53 (hep29217-bib-0038-20241017) 2006; 4 (hep29217-bib-0021-20241017) 1998; 93 29105100 - Hepatology. 2018 Feb;67(2):799-800. doi: 10.1002/hep.29635. 29105109 - Hepatology. 2018 Feb;67(2):798-799. doi: 10.1002/hep.29637. |
| References_xml | – year: 2011 – volume: 12 start-page: 826 year: 2013 end-page: 827 article-title: ARFI and transient elastography for characterization of cystic fibrosis related liver disease: first longitudinal follow‐up data in adult patients publication-title: J Cyst Fibros – volume: 14 start-page: 194 year: 2011 end-page: 206 article-title: Medical resource utilisation and healthcare costs in patients with chronic hepatitis C viral infection and thrombocytopenia publication-title: J Med Econ – volume: 33 start-page: 748 year: 2013 end-page: 758 article-title: Nodular regenerative hyperplasia in common variable immunodeficiency publication-title: J Clin Immunol – volume: 7 start-page: 252 year: 2008 end-page: 257 article-title: A single centre experience of liver disease in adults with cystic fibrosis 1995‐2006 publication-title: J Cyst Fibros – volume: 36 start-page: 1374 year: 2002 end-page: 1382 article-title: Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome publication-title: Hepatology – volume: 64 start-page: 505 year: 2017 end-page: 511 article-title: Correlation of transient elastography with severity of cystic fibrosis related liver disease publication-title: J Pediatr Gastroenterol Nutr – volume: 14 start-page: 1207 year: 2016 end-page: 1215 article-title: Features of severe liver disease with portal hypertension in patients with cystic fibrosis publication-title: Clin Gastroenterol Hepatol – volume: 43 start-page: 1241 year: 2008 end-page: 1248 article-title: ASAT/ALAT ratio provides prognostic information independently of Child‐Pugh class, gender and age in non‐alcoholic cirrhosis publication-title: Scand J Gastroenterol – volume: 124 start-page: 393 year: 1994 end-page: 399 article-title: Anaylsis of risk factors for the development of liver disease associated with cystic fibrosis publication-title: J Pediatr – volume: 43 start-page: 1317 year: 2006 end-page: 1325 article-title: Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection publication-title: Hepatology – volume: 48 start-page: 1425 year: 2001 end-page: 1429 article-title: Nodular regenerative hyperplasia of the liver. A review of 14 cases publication-title: Hepatogastroenterology – volume: 93 start-page: 44 year: 1998 end-page: 48 article-title: AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection publication-title: Am J Gastroenterol – volume: 8 start-page: 392 year: 2009 end-page: 399 article-title: Non‐invasive liver elastography (FibroScan) for detection of cystic fibrosis‐associated liver disease publication-title: J Cyst Fibros – volume: 44 start-page: 7 year: 2006 end-page: 14 article-title: Nodular regenerative hyperplasia: not all nodules are created equal publication-title: Hepatology – volume: 29 start-page: 139 year: 2015 end-page: 144 article-title: Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis publication-title: Can J Gastroenterol Hepatol – volume: 43 start-page: 858 year: 2009 end-page: 864 article-title: Hepatobiliary abnormalities and disease in cystic fibrosis epidemiology and outcomes through adulthood publication-title: J Clin Gastroenterol – volume: 38 start-page: 518 year: 2003 end-page: 526 article-title: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C publication-title: Hepatology – volume: 7 start-page: e42139 year: 2012 article-title: Non‐invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores publication-title: PLoS One – volume: 42 start-page: 848 year: 2016 end-page: 854 article-title: Longitudinal transient elastography measurements used in follow‐up for patients with cystic fibrosis publication-title: Ultrasound Med Biol – volume: 33 start-page: 698 year: 2013 end-page: 705 article-title: Utility of transient elastography in the non‐invasive evaluation of cystic fibrosis liver disease publication-title: Liver Int – volume: 62 start-page: 932 year: 2015 end-page: 954 article-title: Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus publication-title: Hepatology – volume: 28 start-page: S1 issue: Suppl. 1 year: 1999 end-page: S13 article-title: Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group publication-title: J Pediatr Gastroenterol Nutr – volume: 35 start-page: 2343 year: 2015 end-page: 2353 article-title: Chronic liver injury induced by drugs: a systematic review publication-title: Liver Int – volume: 40 start-page: 1231 year: 2010 end-page: 1235 article-title: Transient elastography in patients with cystic fibrosis publication-title: Pediatr Radiol – volume: 127 start-page: 565 year: 1995 end-page: 570 article-title: Cystic fibrosis–associated colitis and fibrosing colonopathy publication-title: J Pediatr – volume: 62 start-page: 1576 year: 2015 end-page: 1583 article-title: Aspartate aminotransferase to platelet ratio and fibrosis‐4 as biomarkers in biopsy‐validated pediatric cystic fibrosis liver disease publication-title: Hepatology – volume: 29 start-page: 1705 year: 2003 end-page: 1713 article-title: Transient elastography: a new noninvasive method for assessment of hepatic fibrosis publication-title: Ultrasound Med Biol – volume: 11 start-page: 787 year: 1990 end-page: 797 article-title: Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules publication-title: Hepatology – volume: 37 start-page: 887 year: 2013 end-page: 894 article-title: Long‐term outcome of chronic hepatitis C after sustained virological response to interferon‐based therapy publication-title: Aliment Pharmacol Ther – volume: 16 start-page: 1005 year: 2009 end-page: 1010 article-title: Value of transient elastography in noninvasive assessment in children's hepatic fibrosis publication-title: [in French] Arch Pediatr – volume: 352 start-page: 1992 year: 2005 end-page: 2001 article-title: Mechanisms of disease: cystic fibrosis publication-title: N Engl J Med – volume: 13 start-page: 529 year: 2007 end-page: 536 article-title: Liver disease in cystic fibrosis publication-title: Curr Opin Pulm Med – volume: 4 start-page: 387 year: 2006 end-page: 394 article-title: Nodular regenerative hyperplasia and severe portal hypertension in cystinosis publication-title: Clin Gastroenterol Hepatol – volume: 30 start-page: 1151 year: 1999 end-page: 1158 article-title: Natural history of liver disease in cystic fibrosis publication-title: Hepatology – volume: 53 start-page: 193 year: 2011 end-page: 201 article-title: Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy publication-title: Hepatology – volume: 134 start-page: 1917 year: 2008 end-page: 1926 article-title: Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease publication-title: Gastroenterology – volume: 135 start-page: 823 year: 2015 end-page: 828 article-title: Factors associated with the platelet count in patients with chronic hepatitis C publication-title: Thromb Res – volume: 10 start-page: S29 issue: Suppl. 2 year: 2011 end-page: S36 article-title: Best practice guidance for the diagnosis and management of cystic fibrosis‐associated liver disease publication-title: J Cyst Fibros – volume: 12 start-page: 116 year: 2013 end-page: 124 article-title: Cirrhosis and other liver disease in cystic fibrosis publication-title: J Cyst Fibros – volume: 163 start-page: 218 year: 2003 end-page: 224 article-title: Validity and clinical utility of the aspartate aminotransferase–alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus–related chronic liver disease publication-title: Arch Intern Med – volume: 45 start-page: 675 year: 2007 end-page: 683 article-title: Hepatic abnormalities in patients with chronic granulomatous disease publication-title: Hepatology – volume: 2 start-page: 340 year: 2001 end-page: 349 article-title: Liver disease in children with cystic fibrosis publication-title: Paediatr Respir Rev – volume: 48 start-page: 835 year: 2008 end-page: 847 article-title: Non‐invasive evaluation of liver fibrosis using transient elastography publication-title: J Hepatol – volume: 8 start-page: 392 year: 2009 ident: hep29217-bib-0027-20241017 article-title: Non‐invasive liver elastography (FibroScan) for detection of cystic fibrosis‐associated liver disease publication-title: J Cyst Fibros doi: 10.1016/j.jcf.2009.08.001 – volume: 62 start-page: 1576 year: 2015 ident: hep29217-bib-0033-20241017 article-title: Aspartate aminotransferase to platelet ratio and fibrosis‐4 as biomarkers in biopsy‐validated pediatric cystic fibrosis liver disease publication-title: Hepatology doi: 10.1002/hep.28016 – volume: 135 start-page: 823 year: 2015 ident: hep29217-bib-0034-20241017 article-title: Factors associated with the platelet count in patients with chronic hepatitis C publication-title: Thromb Res doi: 10.1016/j.thromres.2015.02.010 – volume: 35 start-page: 2343 year: 2015 ident: hep29217-bib-0043-20241017 article-title: Chronic liver injury induced by drugs: a systematic review publication-title: Liver Int doi: 10.1111/liv.12958 – volume: 43 start-page: 1317 year: 2006 ident: hep29217-bib-0019-20241017 article-title: Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection publication-title: Hepatology doi: 10.1002/hep.21178 – volume: 53 start-page: 193 year: 2011 ident: hep29217-bib-0014-20241017 article-title: Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy publication-title: Hepatology doi: 10.1002/hep.24014 – volume: 64 start-page: 505 year: 2017 ident: hep29217-bib-0031-20241017 article-title: Correlation of transient elastography with severity of cystic fibrosis related liver disease publication-title: J Pediatr Gastroenterol Nutr doi: 10.1097/MPG.0000000000001448 – volume: 14 start-page: 1207 year: 2016 ident: hep29217-bib-0026-20241017 article-title: Features of severe liver disease with portal hypertension in patients with cystic fibrosis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2016.03.041 – volume: 7 start-page: 252 year: 2008 ident: hep29217-bib-0010-20241017 article-title: A single centre experience of liver disease in adults with cystic fibrosis 1995‐2006 publication-title: J Cyst Fibros doi: 10.1016/j.jcf.2007.10.004 – volume: 12 start-page: 116 year: 2013 ident: hep29217-bib-0013-20241017 article-title: Cirrhosis and other liver disease in cystic fibrosis publication-title: J Cyst Fibros doi: 10.1016/j.jcf.2012.11.010 – volume: 10 start-page: S29 issue: Suppl. 2 year: 2011 ident: hep29217-bib-0012-20241017 article-title: Best practice guidance for the diagnosis and management of cystic fibrosis‐associated liver disease publication-title: J Cyst Fibros – volume: 352 start-page: 1992 year: 2005 ident: hep29217-bib-0002-20241017 article-title: Mechanisms of disease: cystic fibrosis publication-title: N Engl J Med doi: 10.1056/NEJMra043184 – volume: 36 start-page: 1374 year: 2002 ident: hep29217-bib-0009-20241017 article-title: Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome publication-title: Hepatology doi: 10.1002/hep.1840360613 – volume: 33 start-page: 698 year: 2013 ident: hep29217-bib-0011-20241017 article-title: Utility of transient elastography in the non‐invasive evaluation of cystic fibrosis liver disease publication-title: Liver Int doi: 10.1111/liv.12113 – volume: 29 start-page: 139 year: 2015 ident: hep29217-bib-0032-20241017 article-title: Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis publication-title: Can J Gastroenterol Hepatol doi: 10.1155/2015/138530 – volume: 7 start-page: e42139 year: 2012 ident: hep29217-bib-0016-20241017 article-title: Non‐invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores publication-title: PLoS One doi: 10.1371/journal.pone.0042139 – volume: 12 start-page: 826 year: 2013 ident: hep29217-bib-0015-20241017 article-title: ARFI and transient elastography for characterization of cystic fibrosis related liver disease: first longitudinal follow‐up data in adult patients publication-title: J Cyst Fibros doi: 10.1016/j.jcf.2013.04.004 – volume: 38 start-page: 518 year: 2003 ident: hep29217-bib-0018-20241017 article-title: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C publication-title: Hepatology doi: 10.1053/jhep.2003.50346 – volume: 2 start-page: 340 year: 2001 ident: hep29217-bib-0007-20241017 article-title: Liver disease in children with cystic fibrosis publication-title: Paediatr Respir Rev – volume: 48 start-page: 835 year: 2008 ident: hep29217-bib-0023-20241017 article-title: Non‐invasive evaluation of liver fibrosis using transient elastography publication-title: J Hepatol doi: 10.1016/j.jhep.2008.02.008 – volume: 14 start-page: 194 year: 2011 ident: hep29217-bib-0024-20241017 article-title: Medical resource utilisation and healthcare costs in patients with chronic hepatitis C viral infection and thrombocytopenia publication-title: J Med Econ doi: 10.3111/13696998.2011.562266 – volume: 43 start-page: 858 year: 2009 ident: hep29217-bib-0004-20241017 article-title: Hepatobiliary abnormalities and disease in cystic fibrosis epidemiology and outcomes through adulthood publication-title: J Clin Gastroenterol doi: 10.1097/MCG.0b013e31819e8bbd – volume: 28 start-page: S1 issue: Suppl. 1 year: 1999 ident: hep29217-bib-0005-20241017 article-title: Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group publication-title: J Pediatr Gastroenterol Nutr – volume: 11 start-page: 787 year: 1990 ident: hep29217-bib-0042-20241017 article-title: Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules publication-title: Hepatology doi: 10.1002/hep.1840110512 – volume: 48 start-page: 1425 year: 2001 ident: hep29217-bib-0041-20241017 article-title: Nodular regenerative hyperplasia of the liver. A review of 14 cases publication-title: Hepatogastroenterology – volume: 44 start-page: 7 year: 2006 ident: hep29217-bib-0040-20241017 article-title: Nodular regenerative hyperplasia: not all nodules are created equal publication-title: Hepatology doi: 10.1002/hep.21258 – volume: 30 start-page: 1151 year: 1999 ident: hep29217-bib-0006-20241017 article-title: Natural history of liver disease in cystic fibrosis publication-title: Hepatology doi: 10.1002/hep.510300527 – volume: 124 start-page: 393 year: 1994 ident: hep29217-bib-0008-20241017 article-title: Anaylsis of risk factors for the development of liver disease associated with cystic fibrosis publication-title: J Pediatr doi: 10.1016/S0022-3476(94)70361-2 – volume: 13 start-page: 529 year: 2007 ident: hep29217-bib-0001-20241017 article-title: Liver disease in cystic fibrosis publication-title: Curr Opin Pulm Med doi: 10.1097/MCP.0b013e3282f10a16 – volume: 42 start-page: 848 year: 2016 ident: hep29217-bib-0029-20241017 article-title: Longitudinal transient elastography measurements used in follow‐up for patients with cystic fibrosis publication-title: Ultrasound Med Biol doi: 10.1016/j.ultrasmedbio.2015.11.011 – volume: 4 start-page: 387 year: 2006 ident: hep29217-bib-0038-20241017 article-title: Nodular regenerative hyperplasia and severe portal hypertension in cystinosis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2005.12.013 – volume: 45 start-page: 675 year: 2007 ident: hep29217-bib-0037-20241017 article-title: Hepatic abnormalities in patients with chronic granulomatous disease publication-title: Hepatology doi: 10.1002/hep.21524 – volume: 29 start-page: 1705 year: 2003 ident: hep29217-bib-0044-20241017 article-title: Transient elastography: a new noninvasive method for assessment of hepatic fibrosis publication-title: Ultrasound Med Biol doi: 10.1016/j.ultrasmedbio.2003.07.001 – volume: 93 start-page: 44 year: 1998 ident: hep29217-bib-0021-20241017 article-title: AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.1998.044_c.x – volume: 134 start-page: 1917 year: 2008 ident: hep29217-bib-0025-20241017 article-title: Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.02.081 – volume: 16 start-page: 1005 year: 2009 ident: hep29217-bib-0030-20241017 article-title: Value of transient elastography in noninvasive assessment in children's hepatic fibrosis publication-title: [in French] Arch Pediatr – volume: 127 start-page: 565 year: 1995 ident: hep29217-bib-0039-20241017 article-title: Cystic fibrosis–associated colitis and fibrosing colonopathy publication-title: J Pediatr doi: 10.1016/S0022-3476(95)70113-3 – volume: 40 start-page: 1231 year: 2010 ident: hep29217-bib-0028-20241017 article-title: Transient elastography in patients with cystic fibrosis publication-title: Pediatr Radiol doi: 10.1007/s00247-009-1531-z – volume: 163 start-page: 218 year: 2003 ident: hep29217-bib-0022-20241017 article-title: Validity and clinical utility of the aspartate aminotransferase–alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus–related chronic liver disease publication-title: Arch Intern Med doi: 10.1001/archinte.163.2.218 – volume: 43 start-page: 1241 year: 2008 ident: hep29217-bib-0020-20241017 article-title: ASAT/ALAT ratio provides prognostic information independently of Child‐Pugh class, gender and age in non‐alcoholic cirrhosis publication-title: Scand J Gastroenterol doi: 10.1080/00365520802158614 – volume: 62 start-page: 932 year: 2015 ident: hep29217-bib-0017-20241017 article-title: Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus publication-title: Hepatology doi: 10.1002/hep.27950 – volume: 37 start-page: 887 year: 2013 ident: hep29217-bib-0035-20241017 article-title: Long‐term outcome of chronic hepatitis C after sustained virological response to interferon‐based therapy publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12273 – volume: 33 start-page: 748 year: 2013 ident: hep29217-bib-0036-20241017 article-title: Nodular regenerative hyperplasia in common variable immunodeficiency publication-title: J Clin Immunol doi: 10.1007/s10875-013-9873-6 – reference: 29105109 - Hepatology. 2018 Feb;67(2):798-799. doi: 10.1002/hep.29637. – reference: 29105100 - Hepatology. 2018 Feb;67(2):799-800. doi: 10.1002/hep.29635. |
| SSID | ssj0009428 |
| Score | 2.5219264 |
| Snippet | Cystic fibrosis (CF) liver disease (CFLD), a leading cause of death in CF, is mostly described in pediatric populations. Adult‐onset CFLD lacks sufficient... Cystic fibrosis (CF) liver disease (CFLD), a leading cause of death in CF, is mostly described in pediatric populations. Adult-onset CFLD lacks sufficient... |
| SourceID | pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 591 |
| SubjectTerms | Adult Age of Onset Alanine Alanine transaminase Aspartate aminotransferase Bilirubin Biopsy, Needle Cause of Death Child Child, Preschool Children Cohort Studies Cystic fibrosis Cystic Fibrosis - diagnosis Cystic Fibrosis - epidemiology Diagnosis Female Hepatology Humans Hyperplasia Immunohistochemistry Liver diseases Liver Diseases - diagnosis Liver Diseases - epidemiology Liver Function Tests Male Morbidity Prospective Studies Prothrombin Risk Assessment Severity of Illness Index Survival Analysis |
| Title | Adult‐onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.29217 https://www.ncbi.nlm.nih.gov/pubmed/28422310 https://www.proquest.com/docview/1920069374 https://www.proquest.com/docview/1889765822 https://pubmed.ncbi.nlm.nih.gov/PMC5519421 |
| Volume | 66 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3NbtNAEMdHVQ-ISwuFgqGgpeLQi1Pba-86cKpoqggpCCEq9VDJWm921YjIjhLnEE48Qp-xT8LM-iMNAQn1Znkn8tfM7n-zM78FeK-ImyVV5Kt0LHCCorSf52HoGx1FOeHKtaDi5NEXMbyMP18lVzvwsa2FqfkQ3R9uFBmuv6YAV_nidA0NvTGzXtRHRY39L-VqkSD6tkZH9WO3ryrOugJaXe63VKEgOu1-uTkWbQnM7TzJ-_rVDUAX-3Dd3nqdd_Kjt6zynv75B9Xxgc_2BPYaYcrOak96CjumOIBHo2bp_RlMzojUcffrltKvK6ZXBHhmFi9TLiYLNqX8DtYs93xg53UGHzaoYsx0R4Wuiz5ZafE8o_q1OUHNDTmIGTNXM7x6DpcXg--fhn6zT4Ov45hLP9SSprZc5FLSdkoKJ-jCBiIdY-clCGgoZcq55TpNEqEtypI8MCGPNWqzPlf8EHaLsjAvgVkUjDgpMjIQJo4TpaRNtLGW6oWtlokHJ-0Xy3QDMae9NKZZjV-OMnx1mXt1Hhx3prOa3PE3o6P2s2dN8C4yFL0EcOYy9uBd14xhR2spqjDlEm3SFIVcgvLKgxe1l3RXwRE_Itnsgdzwn86AkN6bLcXkxqG9Ub-i44b4mM49_n3j2XDw1R28-n_T1_A4IlHi0hePYLeaL80blFRV_tbFzm_moh6p |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkGgv5VHaptBiUA9csiRxYmerXlABLY9FqAKJC4ocry1WRVnE7h7oiZ_Ab-wv6YzzgIVWQtyieKLEyUz8jWfmG4CvinizpIp8lfYEOihK-3kehr7RUZQTXbkWVJzcPRKd03j_LDmbgu91LUzJD9FsuJFluP81GThtSG_es4ZemKtW1EZI_QpmqKO3c6h-3pNHtWPXWRX9roDiy-2aVyiINptLJ1ejJxDzaabkQwTrlqDdOTivH77MPPnVGo_ylv79iNfxpbObh7cVNmVbpTItwJQpFmG2W0Xf30F_i8g6_tzeUQb2iOkb4nhmFu8zGPaH7JJSPFgV8fnGtsskPhxQRY_phhi6rPtkA4vnGZWwXROvuSEdMT3myoZvluB0d-fkR8evWjX4Oo659EMtybvlIpeSOiop9NGFDUTaw_-XIE5DKVPOLddpkghtEZnkgQl5rBGetbni72G6GBTmIzCLmBH9IiMDYeI4UUraRBtrqWTYapl4sFF_skxXPObUTuMyKxmYowxfXeZenQfrjehVSd7xL6GV-rtnlf0OM8S9xOHMZezBWjOMlkfhFFWYwRhl0hSxXIIIy4MPpZo0d8FFPyLk7IGcUKBGgFi9J0eK_oVj90YIi5ob4jSdfvz_wbPOzrE7-PR80VV43TnpHmaHe0cHy_AmIozishlXYHp0PTafEWGN8i_OkP4CrsYixA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1LbxMxEMdHpZUqLkB5Li3FIA5cNt1de-0NnKqmUXi0qhCVekBaeb22GlFtoiY5lBMfoZ-RT8KM99GmBQlxi-KJ9jWz_k888zPAG03cLKWTUGelxARFm7Ao4ji0JkkKwpUbSc3JB4dydCw-nqQnK_C-7YWp-RDdH24UGf59TQE-Ld3OFTT01E57SR8V9R1YEzLKyKUHX67YUX3hN1bFtCui5eV-ixWKkp3up8uT0S2FebtQ8rqA9TPQ8D58a8-9Ljz53lvMi575cQPr-J8X9wDuNcqU7dautAErtnoI6wfN2vsjGO8SquPXz0uqv54zc0GEZ-bwMJPZeMbOqMCDNes979igLuHDAV2VzHRY6Lrrk00cfs-oge2cqOaWPMSWzDcNXzyG4-H-171R2GzUEBohuApjoyi35bJQivZT0pihSxfJrMS3lySioVIZ546bLE2lcahLisjGXBgUZ32u-RNYrSaVfQbMoWLErMiqSFohUq2VS411jhqGnVFpAG_bJ5abhmJOm2mc5TV_Ocnx1uX-1gXwujOd1uiOPxlttY89b6J3lqPqJYIzVyKAV90wxh0tpujKThZok2Wo5FLUVwE8rb2kOwpO-Qnp5gDUkv90BsT0Xh6pxqee7Y0CFh03xsv07vH3E89H-0f-w_N_N30J60eDYf75w-GnTbibkEDxpYxbsDo_X9gXKK_mxbYPo99T_CF8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adult+Onset+Cystic+Fibrosis+Liver+Disease%3A+Diagnosis+and+characterization+of+an+underappreciated+entity&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Koh%2C+Christopher&rft.au=Sakiani%2C+Sasan&rft.au=Surana%2C+Pallavi&rft.au=Zhao%2C+Xiongce&rft.date=2017-08-01&rft.issn=0270-9139&rft.eissn=1527-3350&rft.volume=66&rft.issue=2&rft.spage=591&rft.epage=601&rft_id=info:doi/10.1002%2Fhep.29217&rft_id=info%3Apmid%2F28422310&rft.externalDocID=PMC5519421 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon |